Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Structure Therapeutics stock soars 103% as its oral obesity drug aleniglipron shows strong Phase 2b weight-loss results.

Structure Therapeutics Inc. ADR (NASDAQ:GPCR) soared 28.8% in Monday’s premarket trading after releasing strong topline results from its ACCESS clinical program evaluating aleniglipron, an oral GLP-1 ...

The company stated that results from aleniglipron achieved a mean weight loss of 11.3% at 36 weeks in the Phase 2b ACCESS ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

The antidote to your frazzled nerves might just be sitting along the Salmon Falls River, minding its own business. Somersworth represents everything our overstimulated brains desperately need but ...

Mixed chimerism or relapses following TSC-101 infusions were found to be significantly associated with greater ex vivo expansion of TCR-T cells during the manufacturing process. A new commercial-ready ...

Social Security is a major source of income for 74.5M Americans. How far does your check go? See averages by age and gender, ...

Modern neural networks, with billions of parameters, are so overparameterized that they can "overfit" even random, ...

When the FORTRAN programming language debuted in 1957, it transformed how scientists and engineers programmed computers.

Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...

When was Unique molecule-inspired structure in Brussels built for the 1958 Brussels World's Fair, that was meant to be temporary crossword clue used most recently? This clue was last seen in the ...